tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RVMD Stock Latest News

Revolution Medicines price target raised to $71 from $70 at JPMorgan
The FlyRevolution Medicines price target raised to $71 from $70 at JPMorgan
2d ago
RVMD
These 2 Stocks Could Be Prime Takeover Targets, According to Analysts
PremiumStock Analysis & Ideas
These 2 Stocks Could Be Prime Takeover Targets, According to Analysts
3d ago
JAMF
RVMD
Revolution Medicines resumed with a Strong Buy at Raymond James
PremiumThe Fly
Revolution Medicines resumed with a Strong Buy at Raymond James
15d ago
RVMD
Revolution Medicines rises 14.2%
PremiumThe Fly
Revolution Medicines rises 14.2%
15d ago
RVMD
Morning Movers: Kroger rises following second quarter results
PremiumThe Fly
Morning Movers: Kroger rises following second quarter results
15d ago
KR
CNC
Revolution Medicines announces results from daraxonrasib Phase 1 trials
PremiumThe FlyRevolution Medicines announces results from daraxonrasib Phase 1 trials
16d ago
RVMD
Promising Position of Revolution Medicines’ Zoldonrasib Justifies Buy Rating
Premium
Ratings
Promising Position of Revolution Medicines’ Zoldonrasib Justifies Buy Rating
16d ago
RVMD
Revolution Medicines price target raised to $70 from $67 at Wells Fargo
Premium
The Fly
Revolution Medicines price target raised to $70 from $67 at Wells Fargo
16d ago
RVMD
Promising Potential of Daraxonrasib in Pancreatic Cancer Boosts Buy Rating for Revolution Medicines
PremiumRatings
Promising Potential of Daraxonrasib in Pancreatic Cancer Boosts Buy Rating for Revolution Medicines
16d ago
RVMD
Promising Clinical Trials and Strategic Design Drive Buy Rating for Revolution Medicines
PremiumRatings
Promising Clinical Trials and Strategic Design Drive Buy Rating for Revolution Medicines
16d ago
RVMD
Revolution Medicines Reports Promising Phase 1 Study Results
PremiumCompany Announcements
Revolution Medicines Reports Promising Phase 1 Study Results
16d ago
8K
RVMD
Leerink says competitor data suggest promising view for Revolution’s zoldonrasib
PremiumThe Fly
Leerink says competitor data suggest promising view for Revolution’s zoldonrasib
18d ago
RVMD
VSTM
Revolution Medicines initiated with a Buy at Truist
PremiumThe FlyRevolution Medicines initiated with a Buy at Truist
22d ago
RVMD
Piper starts Revolution Medicines at Overweight on daraxonrasib potential
Premium
The Fly
Piper starts Revolution Medicines at Overweight on daraxonrasib potential
1M ago
RVMD
Revolution Medicines initiated with an Overweight at Piper Sandler
Premium
The Fly
Revolution Medicines initiated with an Overweight at Piper Sandler
1M ago
RVMD
Revolution Medicines initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Revolution Medicines initiated with an Outperform at LifeSci Capital
1M ago
RVMD
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
1M ago
BJ
PH
Revolution Medicines initiated with an Overweight at Wells Fargo
PremiumThe Fly
Revolution Medicines initiated with an Overweight at Wells Fargo
1M ago
RVMD
Revolution Medicines’ Innovative RAS(ON) Platform and Strategic Collaborations Drive Buy Rating
PremiumRatings
Revolution Medicines’ Innovative RAS(ON) Platform and Strategic Collaborations Drive Buy Rating
2M ago
RVMD
Revolution Medicines’ Earnings Call: Progress Amid Challenges
PremiumCompany AnnouncementsRevolution Medicines’ Earnings Call: Progress Amid Challenges
2M ago
RVMD
Optimistic Outlook for Revolution Medicines Amid Strategic Developments and Pipeline Progress
Premium
Ratings
Optimistic Outlook for Revolution Medicines Amid Strategic Developments and Pipeline Progress
2M ago
RVMD
Revolution Medicines Advances RAS-Targeted Therapies
Premium
Company Announcements
Revolution Medicines Advances RAS-Targeted Therapies
2M ago
RVMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >